Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis

Abstract

Background:

Progranulin (GRN) is a multifunctional protein involved in inflammation and repair, and also a neurotrophic factor critical for neuronal survival. Progranulin is strongly expressed in multiple sclerosis (MS) brains by macrophages and microglia.

Methods:

In this study we evaluated GRN genetic variability in 400 MS patients, in correlation with clinical variables such as disease severity and relapse recovery. We also evaluated serum progranulin levels in the different groups of GRN variants carriers.

Results:

We found that incomplete recovery after a relapse is correlated with an increased frequency of the rs9897526 A allele (odds ratio (OR) 4.367, p = 0.005). A more severe disease course (Multiple Sclerosis Severity Score > 5) is correlated with an increased frequency of the rs9897526 A allele (OR 1.886, p = 0.002) and of the rs5848 T allele (OR 1.580, p = 0.019). Carriers of the variants associated with a more severe disease course (rs9897526 A, rs5848 T) have significantly lower levels of circulating progranulin (80.5 ± 9.1 ng/mL vs. 165.7 ng/mL, p = 0.01).

Conclusion:

GRN genetic polymorphisms likely influence disease course and relapse recovery in MS.

Keywords

Multiple sclerosis progranulin genetic neuroprotection inflammation relapse disability

Get full access to this article

View all access options for this article.

References

Ahmed

Mackenzie

Hutton

. Progranulin in frontotemporal lobar degeneration and neuroinflammation. J Neuroinflammation 2007; 4(7): 1–13.

Van Damme

Van Hoecke

Lambrechts

. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 2008; 181: 37–41.

Baker

Mackenzie

Pickering-Brown

. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916–919.

Rademakers

Eriksen

Baker

. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP-43-positive frontotemporal dementia. Hum Mol Genet 2008; 17: 3631–3642.

Galimberti

Fenoglio

Cortini

. GRN variability contributes to sporadic frontotemporal lobar degeneration. J Alzheimers Dis 2010; 19: 171–177.

Fenoglio

Galimberti

Cortini

. Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer’s disease. J Alzheimers Dis 2009; 18: 603–612.

Sleegers

Brouwers

Maurer-Stroh

. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology 2008; 71: 253–259.

Vercellino

Grifoni

Romagnolo

. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis. Mult Scler 2011; 17: 1194–1201.

Galimberti

Dell’Osso

Altamura

. Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis. Biol Psychiatry. Epub ahead of print 8 April 2015. DOI: 10.1016/j.biopsych.2015.03.028.

10.

Kutzelnigg

Lucchinetti

Stadelmann

. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705–2712.

11.

Vercellino

Plano

Votta

. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 1101–1107.

12.

Fenoglio

Scalabrini

Esposito

. Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males. Genes Immun 2010; 11: 497–503.

13.

Roxburgh

Seaman

Masterman

. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144–1151.

14.

Vercellino

Romagnolo

Mattioda

. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants. Acta Neurol Scand 2009; 119: 126–130.

15.

Benjamini

Hochberg

. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995; 57: 289–300.

16.

Yin

Banerjee

Thomas

. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 2010; 207: 117–128,S1–S4.

17.

Hohlfeld

. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis? J Neurol Sci 2008; 265: 93–96.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB

0.10 MB